Struggling Avivagen exploring potential sale as part of strategic review

Cows eating

Avivagen is reviewing “strategic alternatives” that could include selling the embattled Ottawa-based life sciences company as it struggles to gain market traction for its natural immune-boosting compound.

Already an Insider? Log in

Get Instant Access to This Article

Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.

Get our email newsletters

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.

By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.